Publication | Closed Access

An I.T.M.O. group study on second-line treatment in advanced epithelial ovarian cancer: an attempt to identify clinical and biological factors determining prognosis

Second-line TreatmentBiological FactorsMedicineCancer ManagementGynecologyGroup StudyCancer TreatmentOncologyRadiation OncologyGynecology OncologyEndocrine-related CancerOvarian Cancer